Shagreen Patch in Tuberous Sclerosis Complex at High-Frequency Ultrasound Authors: Corrado Tagliati, Ximena Wortsman, Giorgio Treglia Published: 2025 ABSTRACT AbstractWe present a case of a 19-year-old female patient with tuberous sclerosis complex and a shagreen patch on her left dorsal region. Decreased echogenicity and increased thickness of the dermis were shown by high-frequency ultrasound. To the best of our knowledge, this is the first reported ultrasound image of a shagreen patch.Keywords: shagreen patch, tuberous sclerosis complex, high-frequency ultrasound, dermis, skin, hypoechoic, thickening Greyscale, longitudinal panoramic view ultrasound image of a shagreen patch in tuberous sclerosis complex in the left dorsal region. Ultrasound examination was performed using a Logic E9 XD Clear ultrasound device (Logiq E9XD, General Electric Health System Clear, Waukesha, WI, USA), using a linear probe with a frequency that ranges from 8 to 18 MHz. Notice the focal zone (*) with decreased echogenicity and increased thickness of the dermis (D), which represents the collagen rich-region (CRR) between the epidermis (E) and dermal–subdermal junction (DSJ). The patient had histologic confirmation after surgical excision performed due to significant distress related to the large size and aesthetic reasons. The patient had facial angiofibromas and ungual fibromas, too. A shagreen patch is one of the major diagnostic criteria for tuberous sclerosis complex, with the others being hypomelanotic macules, angiofibroma or fibrous cephalic plaque, ungual fibromas, multiple retinal hamartomas, multiple cortical tubers and/or radial migration lines, subependymal nodules or giant cell astrocytoma, cardiac rhabdomyoma, lymphangiomyomatosis, and angiomyolipomas. A combination of two major clinical features meets the criteria for a definite diagnosis, apart from the combination of lymphangiomyomatosis and angiomyolipomas without other features [1]. Tuberous sclerosis complex is a rare autosomic dominant genetic disorder with an estimated incidence ranging from 1 in 6000 to 1 in 10,000 live births, characterized by the development of hamartomas in multiple organs caused by mutations in the TSC1 (hamartin) or TSC2 (tuberin) genes [2,3,4]. A shagreen patch is a type of connective tissue nevus which previous studies reported in approximately 21% to 83% of patients with tuberous sclerosis complex, and it often appears in the first decade [5,6]. Dark-skinned people seem to have an increased probability of a shagreen patch [7]. It is usually an irregular, firm plaque with a rough texture located on the back, and lesions can be subdivided into small (1 to <4 cm), medium (4 to <8 cm), and large (≥8 cm) ones [5]. It corresponds histologically to collagenoma (or collagenic hamartoma), with relatively acellular and hyaline collagen bundles that replace the dermis, and extends down to the hypodermis [8]. Some very large shagreen patches were previously described in the literature [5,9]. A previously published case described shagreen patch dermoscopic patterns, such as reddish-brown strands that correspond to papillomatosis, as well as dense collagen bundles in the dermis associated with regularly spaced white dots that correspond to eccrine sweat duct openings on the skin surface [10]. Another article showed that shagreen patch dermoscopy can reveal white/yellow structureless areas and reticular vessels [11]. However, to the best of our knowledge, this is the first ultrasound image of a shagreen patch. Author Contributions Conceptualization, C.T. and X.W.; methodology, C.T. and X.W.; data curation, C.T. and X.W.; writing—original draft preparation, C.T. and X.W.; writing—review and editing, C.T. and X.W.; visualization, C.T. and X.W.; supervision, C.T. and X.W. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement Not applicable. In general, single-patient case reports do not require Institutional Review Board approval, as they are typically not classified as research under regulations in the U.S. and Europe. The work was conducted in accordance with the Declaration of Helsinki. Informed Consent Statement Written informed consent has been obtained from the patient to publish this paper. Data Availability Statement Data are contained within the article. Conflicts of Interest The authors declare no conflicts of interest. Funding Statement This research received no external funding. Footnotes Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. References Associated Data Data Availability Statement Data are contained within the article.